38915105|t|Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury.
38915105|a|BACKGROUND: Tau is aberrantly acetylated in various neurodegenerative conditions, including Alzheimer's disease, frontotemporal lobar degeneration (FTLD), and traumatic brain injury (TBI). Previously, we reported that reducing acetylated tau by pharmacologically inhibiting p300-mediated tau acetylation at lysine 174 reduces tau pathology and improves cognitive function in animal models. METHODS: We investigated the therapeutic efficacy of two different antibodies that specifically target acetylated lysine 174 on tau (ac-tauK174). We treated PS19 mice, which harbor the P301S tauopathy mutation that causes FTLD, with anti-ac-tauK174 and measured effects on tau pathology, neurodegeneration, and neurobehavioral outcomes. Furthermore, PS19 mice received treatment post-TBI to evaluate the ability of the immunotherapy to prevent TBI-induced exacerbation of tauopathy phenotypes. Ac-tauK174 measurements in human plasma following TBI were also collected to establish a link between trauma and acetylated tau levels, and single nuclei RNA-sequencing of post-TBI brain tissues from treated mice provided insights into the molecular mechanisms underlying the observed treatment effects. RESULTS: Anti-ac-tauK174 treatment mitigates neurobehavioral impairment and reduces tau pathology in PS19 mice. Ac-tauK174 increases significantly in human plasma 24 h after TBI, and anti-ac-tauK174 treatment of PS19 mice blocked TBI-induced neurodegeneration and preserved memory functions. Anti-ac-tauK174 treatment rescues alterations of microglial and oligodendrocyte transcriptomic states following TBI in PS19 mice. CONCLUSIONS: The ability of anti-ac-tauK174 treatment to rescue neurobehavioral impairment, reduce tau pathology, and rescue glial responses demonstrates that targeting tau acetylation at K174 is a promising neuroprotective therapeutic approach to human tauopathies resulting from TBI or genetic disease.
38915105	5	15	acetylated	Chemical	-
38915105	16	19	tau	Gene	4137
38915105	56	65	tauopathy	Disease	MESH:D024801
38915105	70	82	brain injury	Disease	MESH:D001930
38915105	96	99	Tau	Gene	4137
38915105	114	124	acetylated	Chemical	-
38915105	136	164	neurodegenerative conditions	Disease	MESH:D019636
38915105	176	195	Alzheimer's disease	Disease	MESH:D000544
38915105	197	230	frontotemporal lobar degeneration	Disease	MESH:D057174
38915105	232	236	FTLD	Disease	MESH:D057174
38915105	243	265	traumatic brain injury	Disease	MESH:D000070642
38915105	267	270	TBI	Disease	MESH:D000070642
38915105	311	321	acetylated	Chemical	-
38915105	322	325	tau	Gene	4137
38915105	358	362	p300	Gene	2033
38915105	372	375	tau	Gene	4137
38915105	410	413	tau	Gene	4137
38915105	577	587	acetylated	Chemical	-
38915105	602	605	tau	Gene	4137
38915105	607	617	ac-tauK174	Chemical	-
38915105	636	640	mice	Species	10090
38915105	659	664	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
38915105	665	674	tauopathy	Disease	MESH:D024801
38915105	696	700	FTLD	Disease	MESH:D057174
38915105	712	722	ac-tauK174	Chemical	-
38915105	747	750	tau	Gene	4137
38915105	762	779	neurodegeneration	Disease	MESH:D019636
38915105	824	828	PS19	CellLine	CVCL:9225
38915105	829	833	mice	Species	10090
38915105	858	861	TBI	Disease	MESH:D000070642
38915105	918	921	TBI	Disease	MESH:D000070642
38915105	946	955	tauopathy	Disease	MESH:D024801
38915105	968	978	Ac-tauK174	Chemical	-
38915105	995	1000	human	Species	9606
38915105	1018	1021	TBI	Disease	MESH:D000070642
38915105	1070	1076	trauma	Disease	MESH:D014947
38915105	1081	1091	acetylated	Chemical	-
38915105	1092	1095	tau	Gene	4137
38915105	1144	1148	-TBI	Disease	MESH:D000070642
38915105	1176	1180	mice	Species	10090
38915105	1286	1296	ac-tauK174	Chemical	-
38915105	1317	1343	neurobehavioral impairment	Disease	MESH:D019954
38915105	1356	1359	tau	Gene	4137
38915105	1378	1382	mice	Species	10090
38915105	1384	1394	Ac-tauK174	Chemical	-
38915105	1422	1427	human	Species	9606
38915105	1446	1449	TBI	Disease	MESH:D000070642
38915105	1460	1470	ac-tauK174	Chemical	-
38915105	1489	1493	mice	Species	10090
38915105	1502	1505	TBI	Disease	MESH:D000070642
38915105	1514	1531	neurodegeneration	Disease	MESH:D019636
38915105	1569	1579	ac-tauK174	Chemical	-
38915105	1676	1679	TBI	Disease	MESH:D000070642
38915105	1688	1692	mice	Species	10090
38915105	1727	1737	ac-tauK174	Chemical	-
38915105	1758	1784	neurobehavioral impairment	Disease	MESH:D019954
38915105	1793	1796	tau	Gene	4137
38915105	1863	1866	tau	Gene	4137
38915105	1942	1947	human	Species	9606
38915105	1948	1959	tauopathies	Disease	MESH:D024801
38915105	1975	1978	TBI	Disease	MESH:D000070642
38915105	1982	1997	genetic disease	Disease	MESH:D030342
38915105	Positive_Correlation	MESH:D057174	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
38915105	Association	MESH:D014947	4137
38915105	Positive_Correlation	MESH:D024801	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
38915105	Association	MESH:D000544	4137
38915105	Association	MESH:D057174	4137
38915105	Association	MESH:D030342	4137
38915105	Association	MESH:D001930	4137
38915105	Association	MESH:D000070642	4137
38915105	Association	MESH:D024801	4137
38915105	Association	2033	4137
38915105	Association	MESH:D019636	4137

